Given the importance of EGFR in ovarian cancer and the fact that μ-opioid receptor agonists can activate EGFR, we hypothesized that fentanyl might display pro-ovarian cancer activity via simulating EGFR-mediated signaling. Here, EGFR is linked to ovarian cancer.